Table 3. Use of medications in the management of women who died of postpartum haemorrhage and preeclampsia/eclampsia from reported maternal death cases, 2010 and 2017, Cambodia.
| Cause of death and treatment received | 2010 | 2017 | P |
|---|---|---|---|
| Postpartum haemorrhage cases | 63 | 23 | – |
| Postpartum haemorrhage cases that received: | |||
| Oxytocin, prophylactic | 46 (73.0) | 22 (95.7) | 0.02 |
| Oxytocin, second dose | 8 (12.7) | 7 (30.4) | 0.14 |
| Preeclampsia cases | 27 | 6 | – |
| Preeclampsia cases that received: | |||
| Magnesium sulfate | 10 (37.0) | 4 (66.7) | 0.18 |
| Antihypertensive | 1 (6.7) | 1 (16.7) | 0.48 |
Values are n(%) unless otherwise indicated.